Sanara MedTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1995
Revenue	64.99	45.84	24.14	15.59	11.77	Upgrade
Revenue Growth (YoY)	41.77%	89.87%	54.90%	32.47%	101.56%	Upgrade
Cost of Revenue	7.85	6.36	2.31	1.62	1.21	Upgrade
Gross Profit	57.14	39.48	21.83	13.97	10.56	Upgrade
Selling, General & Admin	56.99	45.98	28.05	18.67	13.18	Upgrade
Research & Development	4.13	3.37	0.56	0.04	0	Upgrade
Other Operating Expenses	3.68	2.37	0.6	0.29	0.12	Upgrade
Operating Expenses	64.8	51.71	29.21	19	13.3	Upgrade
Operating Income	-7.67	-12.23	-7.38	-5.03	-2.74	Upgrade
Interest Expense / Income	0.48	0	0	0.01	0.11	Upgrade
Other Expense / Income	-3.84	1.55	0.55	-0.69	-0.03	Upgrade
Pretax Income	-4.3	-13.78	-7.92	-4.36	-2.81	Upgrade
Income Tax	0	-5.84	0	0	0	Upgrade
Net Income	-4.3	-7.94	-7.92	-4.36	-2.81	Upgrade
Shares Outstanding (Basic)	8	8	7	6	2	Upgrade
Shares Outstanding (Diluted)	8	8	7	6	2	Upgrade
Shares Change	4.71%	7.70%	28.02%	168.88%	-1.79%	Upgrade
EPS (Basic)	-0.52	-1.00	-1.08	-0.76	-1.32	Upgrade
EPS (Diluted)	-0.52	-1.00	-1.08	-0.76	-1.32	Upgrade
Free Cash Flow	-3.51	-5.7	-4.99	-4.58	-2.35	Upgrade
Free Cash Flow Per Share	-0.42	-0.72	-0.68	-0.80	-1.10	Upgrade
Gross Margin	87.92%	86.12%	90.43%	89.63%	89.72%	Upgrade
Operating Margin	-11.79%	-26.68%	-30.55%	-32.30%	-23.29%	Upgrade
Profit Margin	-6.62%	-17.31%	-32.81%	-27.95%	-23.92%	Upgrade
Free Cash Flow Margin	-5.40%	-12.43%	-20.65%	-29.38%	-19.97%	Upgrade
EBITDA	0.19	-11.15	-7.15	-3.94	-2.49	Upgrade
EBITDA Margin	0.29%	-24.32%	-29.61%	-25.25%	-21.15%	Upgrade
Depreciation & Amortization	4.02	2.63	0.77	0.41	0.22	Upgrade
EBIT	-3.83	-13.78	-7.92	-4.34	-2.71	Upgrade
EBIT Margin	-5.89%	-30.06%	-32.81%	-27.88%	-23.02%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).